×

Warning

Joomla\CMS\Filesystem\Folder::create: Could not create folder.Path: /afs/physics.auth.gr/service/www/vhosts/nanoathero.physics.auth.gr/htdocs/cache/com_templates

NanoAthero

"Smart" biodegradable nanoparticles for site-specific treatment of atherosclerosis

NANOATHERO project, characterized by an interdisciplinarity, aims to the exploitation of Nanotechnology tools in order to overcome the limitation of existing cardiovascular approaches.
The main idea of "NanoAthero" is to use an Interdisciplinary methodology based on its applications Nanotechnology with Nanoparticles (NS) as transport vehicles drugs for targeted treatment of atherosclerotic plaques reducing the number of heart attacks; So, innovative approaches will be introduced to the fight against atherosclerosis, such as:
 
  • Nanomedicine for the treatment of vulnerable plaques from smart biodegradable NS that penetrate the endothelium, reach the molecular targets within the plate and release drugs in a controlled manner.

  • Innovative technologies for nano-plastic development transport of anti-inflammatory or antioxidant drugs for clinical applications .

 

Acronym: NanoAthero | Code: Τ2ΕΔΚ-00563

Project Full Title

Development and Preclinical Validation of biofunctionalized Nanoparticles for targeted delivery of anti-oxidant factors to treat Atherosclerosis

Partners

The Consortium is comprised of 3 partners (1 Academic & 2 SMEs)

Duration

2020 - 2022

Coordinator

Nanotechnology Lab LTFN - Aristotle University of Thessaloniki, Greece

Consortium

Nanotechnology Lab LTFN - Aristotle University of Thessaloniki (AUTH)
BL Nanobiomed P.C.
KSA SUPERALLOYS ENG

See information about the Partners

NanoAther Partners
Co - financed by the European Union and Greek national funds through the Operational Programme “Competitiveness, Entrepreneurship and Innovation”, under the call “RESEARCH-CREATE-INNOVATE” (project code: Τ2ΕΔΚ-00563)

Project Information

Code: Τ2ΕΔΚ-00563

Acronym: NanoAthero

Full Title: Development and Preclinical Validation of biofunctionalized Nanoparticles for targeted delivery of anti-oxidant factors to treat Atherosclerosis

Duration: 2020 - 2022

©2021 NanoAthero Project. All Rights Reserved.